501 Results
Sort By:
Published on April 17, 2024
Scientists at the Harvard Pilgrim Health Care Institute have made a breakthrough in understanding the development of gestational diabetes (GDM), focusing on the placenta’s role in the condition that affects approximately 14 percent of pregnancies worldwide. The study, titled “Placental IGFBP1 levels during early pregnancy and the risk of insulin…
Published on February 21, 2024
A new position statement published today in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism states that diabetes care is more effective when the patient experience is taken into account when formulating a treatment plan. This approach, which moves beyond simply taking into account the clinical numbers and focusing…
Published on February 20, 2024
An international group of researchers has carried out a large genome-wide association study (GWAS), including over 2.5 million individuals, to study the genetics of type 2 diabetes. As reported in the journal Nature, the team found 1,289 genetic variants linked with type 2 diabetes, mapping to 611 different positions in…
Published on February 13, 2024
Research from the Mayo Clinic shows that gastric bypass surgery in people with type 2 diabetes results in lasting remission of the disease, even after regaining their weight. The study, published today in the Journal of the American College of Surgeons, shows that gastric bypass patients were more likely to…
Published on January 29, 2024
Researchers at the University of Granada (UGR), Spain have shown that sclerostin, a bone formation inhibitor protein, is also protective of the cardiovascular health of patients with type 2 diabetes. The research was conducted by the MP20-Biomarkers of Metabolic and Bone Diseases research group at the Biohealth Research Institute in…
Published on January 22, 2024
Australian and Norwegian researchers report they have developed a new method of delivering insulin via nano-carriers which may allow diabetes patients to take it orally as opposed to daily insulin injections. The new technology, described in the journal Nature Nanotechnology, notes that its nano-carriers are 1/10,000th the width of a…
Published on January 19, 2024
Weight loss by diet and lifestyle can reverse Type 2 diabetes, evidence suggests. Now, new research shows diabetes remission may reduce cardiovascular disease (CVD) risk by 40% and chronic kidney disease (CKD) by 33%. The study appeared in Diabetologia and was led by Edward Gregg, head of the School of…
Published on January 5, 2024
Results from a large Finnish study show that women with type 1 diabetes are almost four times more likely to have a baby with a congenital heart defect (CHD) than those without diabetes. This association confirms previous research showing a link between maternal type 1 diabetes and CHDs in offspring.…
Published on December 8, 2023
Researchers at Case Western Reserve University say that a class of diabetes drugs used to treat type 2 diabetes may reduce the risk of the development of colorectal cancer (CRC). The drugs, called glucagon-like peptide-1 receptor agonists, or GLP-1 RAs are medications that are given by injection to lower blood…
Published on November 15, 2023
A large-scale, community program run by the U.K.’s National Health Service designed to reduce the risk of developing type 2 diabetes is effective, according to a study led by Stanford University. The ongoing NHS Diabetes Prevention Program (DPP) was set up in 2016 and participants are adults who are at…
Published on October 11, 2023
White patients with diabetes and multiple myeloma have lower overall survival compared to Black patients with the same illnesses, according to a study published in Blood Advances. While research has shown that patients with myeloma and diabetes have poorer survival, this is the first to show racial differences in survival…
Published on October 11, 2023
Heart health experts are declaring the overlapping effects of obesity, Type 2 diabetes, chronic kidney disease, and cardiovascular disease as a new syndrome—cardiovascular-kidney-metabolic syndrome, or CKM. This change, they say, is prompting rethinking of how they predict long-term cardiovascular risks. A presidential advisory from the American Heart Association (AHA), published Monday in the…
Published on September 13, 2023
Research led by Shanghai Jiao Tong University School of Medicine and the Chan School of Public Health in Boston suggests that there may be more long-term health risks associated with gestational diabetes than previously thought even in women who do not go on to develop type 2 diabetes. Using data…
Published on September 6, 2023
The Broad Institute of MIT and Harvard today announced a research alliance with Novo Nordisk in diabetes and cardiometabolic diseases. The collaboration aims to advance three programs over the next three years. Two programs will seek drug targets for specific subtypes of type 2 diabetes and the third aims to…
Published on August 30, 2023
Researchers led by Hiroshi Ohno, MD, PhD, at Japan’s RIKEN Center for Integrative Medical Sciences have identified gut bacteria that reduces insulin resistance and may protect against type 2 diabetes and obesity. Their study, published today in Nature, involved analyzing human fecal microbiomes then corroborating their results with tests on…